NeuroSense Therapeutics Ltd. Depreciation
NeuroSense Therapeutics Ltd. (NRSN) reported Depreciation of $16.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-31
| Period end | Depreciation 6 month | Depreciation 12 month |
|---|---|---|
| 2025-12-31 | $16.00K 20-F · filed 2026-03-31 | |
| 2025-06-30 | $8.00K 6-K · filed 2025-08-01 | |
| 2024-12-31 | $22.00K 20-F · filed 2026-03-31 | |
| 2024-06-30 | $11.00K 6-K · filed 2025-08-01 | |
| 2023-12-31 | $21.00K 20-F · filed 2026-03-31 | |
| 2023-06-30 | $9.00K 6-K · filed 2024-09-30 | |
| 2022-12-31 | $12.00K 20-F · filed 2025-04-07 | |
| 2021-12-31 | $3.00K 6-K · filed 2024-06-17 |